PFE - Cerevel Therapeutics falls on delayed readout
2023-08-02 13:42:49 ET
More on Cerevel
- Cerevel Therapeutics Holdings, Inc. ( CERE ) Q2 2023 Earnings Call Transcript
- Cerevel: High Priced Stock Doing Interesting Science
- Pfizer spinout Cerevel names Bain Capital partner Ron Renaud as new CEO
- Cerevel extends losses as Wells Fargo downgrades after timeline shift for trials
- Seeking Alpha’s Quant Rating on Cerevel Therapeutics
For further details see:
Cerevel Therapeutics falls on delayed readout